Viridian Therapeutics Inc
WKN: A2QMUH / ISIN: US92790C1045Hat MGEN Tenbagger-Potential?
| eröffnet am: | 22.05.19 20:34 von: | moneywork4me |
| neuester Beitrag: | 12.12.23 10:38 von: | Balu4u |
| Anzahl Beiträge: | 91 | |
| Leser gesamt: | 38056 | |
| davon Heute: | 4 | |
bewertet mit 5 Sternen |
||
|
Seite:
1
|
||
22.05.19 20:34
#1
moneywork4me
Hat MGEN Tenbagger-Potential?
Miragen (MGEN) oder unter der WKN A2DLVX auch als Signal Genetics gelistet hat ein Kursziel von 24 USD erhalten, was nahezu einem Tenbagger entspricht. Durchschnittlich immer noch ein KZ von 18 USD:
Wedbush analyst Liana Moussatos reiterated a Buy rating on Miragen Therapeutics Inc (MGEN – Research Report) today and set a price target of $24. The company’s shares opened today at $2.80, close to its 52-week low of $2.20.
According to TipRanks.com, Moussatos ‘ ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -6.8% and a 35.6% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical Inc., Allena Pharmaceuticals Inc, and Aquestive Therapeutics Inc.
Miragen Therapeutics Inc has an analyst consensus of Moderate Buy, with a price target consensus of $18, representing a 542.9% upside. In a report issued on May 9, Oppenheimer also reiterated a Buy rating on the stock with a $12 price target.
https://www.analystratings.com/articles/...ceives-a-buy-from-wedbush/
Über Miragen: http://www.miragen.com/
Wedbush analyst Liana Moussatos reiterated a Buy rating on Miragen Therapeutics Inc (MGEN – Research Report) today and set a price target of $24. The company’s shares opened today at $2.80, close to its 52-week low of $2.20.
According to TipRanks.com, Moussatos ‘ ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -6.8% and a 35.6% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical Inc., Allena Pharmaceuticals Inc, and Aquestive Therapeutics Inc.
Miragen Therapeutics Inc has an analyst consensus of Moderate Buy, with a price target consensus of $18, representing a 542.9% upside. In a report issued on May 9, Oppenheimer also reiterated a Buy rating on the stock with a $12 price target.
https://www.analystratings.com/articles/...ceives-a-buy-from-wedbush/
Über Miragen: http://www.miragen.com/
19.08.19 16:34
#3
moneywork4me
Heute durch die Decke
https://www.nasdaq.com/de/symbol/mgen/real-time
Ohne News?
Ohne News?
27.09.19 18:57
#4
Vassago
MGEN 0,77$ (neues 52 WT)
Miragen´s Zahlen für Q2/19
- Umsatz 2,5 Mio. $
- Verlust 8,9 Mio. $
- Cash 44 Mio. $
- Cashburn pro Quartal 9-11 Mio. $
- Cash-Reichweite ~4 Quartale
- MK 24 Mio. $
http://investors.miragen.com/file/Index?KeyFile=399094977
08.11.19 12:37
#5
Vassago
MGEN 0,71$
Zahlen für Q3/19
- Umsatz 0,7 Mio. $
- Verlust 11 Mio. $
- Cash 34 Mio. $
- Cashreichweite ~3 Quartale
- MK 21 Mio. $
http://investors.miragen.com/file/Index?KeyFile=400886528
12.12.19 16:26
#6
Vassago
MGEN 0,57$ (-17%)
Strategieänderungen
"Extends anticipated cash runway into Q4 2020"
http://investors.miragen.com/file/Index?KeyFile=401560894
24.01.20 19:29
#10
Nobsy11
..nächste Weel wieder auf $ 1,4 ...
https://old.nasdaq.com/de/symbol/mgen/real-time
27.01.20 19:45
#14
Balu4u
Hängt noch an 1,30 USD...
bin gespannt, ob die geknackt wird
https://old.nasdaq.com/de/symbol/mgen/real-time
https://old.nasdaq.com/de/symbol/mgen/real-time
28.01.20 15:52
#16
Balu4u
Weg bis 2 USD frei?
https://old.nasdaq.com/de/symbol/mgen/real-time
30.01.20 14:02
#19
Frozenfrog
Krasse News
Im pre bereits knappe 2 Mio gehandelt.
Das wird bis morgen abend richtig lustig hier...
Das wird bis morgen abend richtig lustig hier...
30.01.20 16:55
#21
Vassago
MGEN 1,98$ (+17%)
vervierfacht in 1,5 Monaten
http://investors.miragen.com/file/Index?KeyFile=402520556
http://investors.miragen.com/file/Index?KeyFile=402520556
30.01.20 17:49
#22
Balu4u
Intraday rebound?
https://old.nasdaq.com/de/symbol/mgen/real-time
04.02.20 19:09
#24
Balu4u
bei 1,80 raus , jetzt wieder 1,20
https://old.nasdaq.com/de/symbol/mgen/real-time
Seite:
1


